VINCRISTINE SULPHATE

Vincristine sulphate is a chemotherapy medication containing vincristine sulphate as the active ingredient. It belongs to the vinca alkaloids class of drugs, which work by inhibiting cancer cell growth. This medication is used to treat blood cancers, head cancers, breast cancers, neck cancers, kidney cancers, bone cancers, and lung cancers. It is also used to treat rhabdomyosarcoma, which is cancer affecting muscle tissue, and neuroblastoma, which is cancer that develops from immature nerve cells. Vincristine sulphate may additionally be used to treat multiple myeloma, which is cancer of plasma cells, thyroid cancer, and idiopathic thrombocytopenic purpura, a blood disorder. Cancer is a disorder characterised by uncontrolled and abnormal cell multiplication. Vincristine sulphate was first approved by the FDA in 1963 for treating acute lymphocytic leukaemia. Since its initial approval, it has received additional approvals for treating other cancer types. As with all chemotherapy drugs, vincristine sulphate can cause side effects including nausea, vomiting, constipation, hair loss, and fatigue. Patients should discuss the potential benefits and risks of treatment with their doctor.

Vincristine sulphate is used to treat various types of cancer, including blood cancers such as acute lymphocytic leukemia (ALL), head and neck cancers, breast cancer, kidney cancer, bone cancer, and lung cancer. It is also used to treat idiopathic thrombocytopenic purpura (a condition in which the immune system attacks and destroys platelets cells) and multiple myeloma (a type of blood cancer that affects plasma cells). In addition, this medication is used to treat rhabdomyosarcoma (cancer that forms in the body's soft tissues) and neuroblastoma (cancer that develops in certain nerve cells). It may also be used to treat thyroid cancer.

A healthcare professional usually administers vincristine sulphate intravenous injection (IV) in a hospital or clinical setting. It should not be taken orally or applied topically to the skin. If you miss a dose, do not double the dose to make up for the missed one.

Vincristine sulphate can cause a range of side effects, which may vary depending on the individual patient and their treatment regimen. Common side effects include nausea, vomiting, constipation, loss of appetite, fatigue, and hair loss. Some patients may also experience nerve damage, which can cause symptoms such as tingling, numbness, or weakness in the hands and feet. Other potential side effects include low blood cell counts, fever, chills, or flu-like symptoms that may indicate an infection or other complications. Rarely, this medication can cause serious side effects such as allergic reactions, seizures, or liver damage.

There are several important warnings associated with the use of vincristine sulphate. First and foremost, this medication should only be used under the close supervision of a qualified healthcare provider because it can be toxic if not administered properly. It can also cause serious and potentially life-threatening side effects like nerve and liver damage. Sometimes this medication can cause reduced blood cell count, which can cause anemia and thrombocytopenia. Patients should be aware that this medication increases the risk of infection and causes rashes and skin problems when it comes to the sun.

Several precautions should be taken when using vincristine sulphate. First, this medication should not be used in patients who are allergic to it or any of its components. Patients with pre-existing nerve damage or other conditions that affect nerve function may be at increased risk for nerve damage, and caution should be taken when using this medication in these patients. Patients require careful monitoring for any signs of infection, bleeding, or anemia. Patients who are pregnant or breastfeeding should not use this medication. Women of reproductive age should use effective contraception while taking this medication to avoid contraception. You should inform their healthcare provider of all medications and supplements they are taking before starting treatment.

If you are undergoing treatment with vincristine sulphate, it is important to actively monitor your health and manage your treatment carefully. Stay in regular contact with your healthcare provider and promptly report any unusual symptoms, concerns, or side effects. Avoid pregnancy and breastfeeding while receiving this treatment. Take care of your physical and emotional well-being, and seek support from family, friends, or healthcare professionals when needed. Following a healthy, balanced diet can also help support your overall health during treatment. Staying informed and actively involved in your care can help reduce potential risks and support the best possible treatment outcomes.

Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865. Hospira UK Ltd, Electronic medicines compendium (EMC), [Revised on March 2022] [ Accessed on 18 April 2023], https://www.medicines.org.uk/emc/files/pil.1501.pdf Hospira, Inc, US Food and Drug Administration, [Revised on July 2013] [ Accessed on 18th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/071484s042lbl.pdf Jan Skubnik et al; Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics; Biology; Published on 31/08/2021; Accessed on 18th April 2023; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468923/